Cargando…
Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
Increasing prescription drug pricing often reflects additional work stress on medical professionals because they function as financial advisors for patients and help them manage out-of-pocket expenses. Providers or prescribers wish to help patients with prescription costs but often lack related info...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838942/ https://www.ncbi.nlm.nih.gov/pubmed/33374493 http://dx.doi.org/10.3390/pharmacy9010001 |
_version_ | 1783643296002736128 |
---|---|
author | Lee, Kah Seng Kassab, Yaman Walid Taha, Nur Akmar Zainal, Zainol Akbar |
author_facet | Lee, Kah Seng Kassab, Yaman Walid Taha, Nur Akmar Zainal, Zainol Akbar |
author_sort | Lee, Kah Seng |
collection | PubMed |
description | Increasing prescription drug pricing often reflects additional work stress on medical professionals because they function as financial advisors for patients and help them manage out-of-pocket expenses. Providers or prescribers wish to help patients with prescription costs but often lack related information. Healthcare plan providers try to display prescription and drug cost information on their websites, but such data may not be linked to electronic prescription software. A mark-up is defined as the additional charges and costs that are applied to the price of a product for the purpose of covering overhead costs, distribution charges, and profit. Therefore, the policies implemented in the pharmaceutical distribution chain might include the regulation of wholesale and retails mark-ups and pharmaceutical remuneration. If mark-ups are regulated, countries are highly recommended to use regressive mark-ups rather than fixed percentage mark-ups. This narrative review provides insights into the framework of pharmaceutical mark-up systems by describing different factors impacting pharmaceutical prices and affordability. These include the interplay of medicine pricing and the supply chain, the impact of pertinent laws and regulation and out-of-pocket expenditure. |
format | Online Article Text |
id | pubmed-7838942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78389422021-01-28 Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review Lee, Kah Seng Kassab, Yaman Walid Taha, Nur Akmar Zainal, Zainol Akbar Pharmacy (Basel) Review Increasing prescription drug pricing often reflects additional work stress on medical professionals because they function as financial advisors for patients and help them manage out-of-pocket expenses. Providers or prescribers wish to help patients with prescription costs but often lack related information. Healthcare plan providers try to display prescription and drug cost information on their websites, but such data may not be linked to electronic prescription software. A mark-up is defined as the additional charges and costs that are applied to the price of a product for the purpose of covering overhead costs, distribution charges, and profit. Therefore, the policies implemented in the pharmaceutical distribution chain might include the regulation of wholesale and retails mark-ups and pharmaceutical remuneration. If mark-ups are regulated, countries are highly recommended to use regressive mark-ups rather than fixed percentage mark-ups. This narrative review provides insights into the framework of pharmaceutical mark-up systems by describing different factors impacting pharmaceutical prices and affordability. These include the interplay of medicine pricing and the supply chain, the impact of pertinent laws and regulation and out-of-pocket expenditure. MDPI 2020-12-23 /pmc/articles/PMC7838942/ /pubmed/33374493 http://dx.doi.org/10.3390/pharmacy9010001 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lee, Kah Seng Kassab, Yaman Walid Taha, Nur Akmar Zainal, Zainol Akbar Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review |
title | Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review |
title_full | Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review |
title_fullStr | Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review |
title_full_unstemmed | Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review |
title_short | Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review |
title_sort | factors impacting pharmaceutical prices and affordability: narrative review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838942/ https://www.ncbi.nlm.nih.gov/pubmed/33374493 http://dx.doi.org/10.3390/pharmacy9010001 |
work_keys_str_mv | AT leekahseng factorsimpactingpharmaceuticalpricesandaffordabilitynarrativereview AT kassabyamanwalid factorsimpactingpharmaceuticalpricesandaffordabilitynarrativereview AT tahanurakmar factorsimpactingpharmaceuticalpricesandaffordabilitynarrativereview AT zainalzainolakbar factorsimpactingpharmaceuticalpricesandaffordabilitynarrativereview |